![Ian Clements](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Clements
Corporate Officer/Principal presso
National Investor Relations Institute
Profilo
Ian Clements is a professional with experience in various firms.
He is currently a member of The Royal Society of Chemistry and the National Investor Relations Institute.
He has previously worked as Director-Marketing Communications at BIOVIA, Inc., Senior Director-Corporate Communications at Sequenom, Inc., Head-Investor Relations & Corporate Communications at Avanir Pharmaceuticals, Inc., VP-Investor Relations & Corporate Communications at Tobira Therapeutics, Inc., and Vice President-Investor Relations at Dermira, Inc. Currently, he is serving as the Chief Financial Officer at Mirum Pharmaceuticals, Inc. Dr. Clements holds a doctorate from The University of Manchester, an undergraduate degree from Staffordshire University, and an MBA from The Open University.
Posizioni attive di Ian Clements
| Società | Posizione | Inizio |
|---|---|---|
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Corporate Officer/Principal | - |
The Royal Society of Chemistry
 The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Corporate Officer/Principal | - |
Precedenti posizioni note di Ian Clements
| Società | Posizione | Fine |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 15/05/2023 |
| DERMIRA, INC. | Contatto Relazioni con gli Investitori | 01/03/2019 |
| TOBIRA THERAPEUTICS INC | Contatto Relazioni con gli Investitori | 01/12/2016 |
| AVANIR PHARMACEUTICALS INC | Contatto Relazioni con gli Investitori | 01/06/2015 |
| ACCELRYS, INC. | Vendite & Marketing | - |
Formazione di Ian Clements
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
74
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
BIOVIA, Inc.
 BIOVIA, Inc. Packaged SoftwareTechnology Services Develops cloud-based and enterprise R&D, modeling and informatics platform | Technology Services |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Sequenom, Inc.
 Sequenom, Inc. Medical/Nursing ServicesHealth Services Provides genomic and genetic analysis solutions | Health Services |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Commercial Services |
Staffordshire University
 Staffordshire University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Open University
 The Open University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
